2022-10-01 2023-09-30 false No description of principal activity Capium Accounts Production 1.1 11562733 bus:AbridgedAccounts 2022-10-01 2023-09-30 11562733 bus:Micro-entities 2022-10-01 2023-09-30 11562733 bus:AuditExemptWithAccountantsReport 2022-10-01 2023-09-30 11562733 bus:SmallCompaniesRegimeForAccounts 2022-10-01 2023-09-30 11562733 bus:PrivateLimitedCompanyLtd 2022-10-01 2023-09-30 11562733 2022-10-01 2023-09-30 11562733 2023-09-30 11562733 bus:RegisteredOffice 2022-10-01 2023-09-30 11562733 core:WithinOneYear 2023-09-30 11562733 core:AfterOneYear 2023-09-30 11562733 bus:Director1 2022-10-01 2023-09-30 11562733 bus:Director1 2023-09-30 11562733 bus:Director1 2021-10-01 2022-09-30 11562733 2021-10-01 11562733 bus:LeadAgentIfApplicable 2022-10-01 2023-09-30 11562733 2021-10-01 2022-09-30 11562733 2022-09-30 11562733 core:WithinOneYear 2022-09-30 11562733 core:AfterOneYear 2022-09-30 11562733 bus:EntityAccountantsOrAuditors 2021-10-01 2022-09-30 11562733 bus:OrdinaryShareClass1 2022-10-01 2023-09-30 11562733 bus:OrdinaryShareClass1 2023-09-30 11562733 bus:OrdinaryShareClass1 2021-10-01 2022-09-30 11562733 bus:OrdinaryShareClass1 2022-09-30 11562733 core:ComputerEquipment 2022-10-01 2023-09-30 11562733 core:ComputerEquipment 2023-09-30 11562733 core:ComputerEquipment 2022-09-30 11562733 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-09-30 11562733 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2022-09-30 11562733 core:CostValuation core:Non-currentFinancialInstruments 2023-09-30 11562733 core:CostValuation core:Non-currentFinancialInstruments 2022-09-30 11562733 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2023-09-30 11562733 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2023-09-30 11562733 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2023-09-30 11562733 core:Non-currentFinancialInstruments 2023-09-30 11562733 core:Non-currentFinancialInstruments 2022-09-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 11562733
England and Wales

 

 

 

MW MEDS LTD


Abridged Accounts
 


Period of accounts

Start date: 01 October 2022

End date: 30 September 2023
  2023   2022
    £ £   £ £
Fixed assets   2,576      1,930 
Current assets 41,094      40,018   
Creditors: amount falling due within one year (9,221)     (10,950)  
Net current assets   31,873      29,068 
Total assets less current liabilities   34,449      30,998 
Net assets   34,449      30,998 
 

         
Capital and reserves   34,449      30,998 
 
NOTES TO THE ACCOUNTS

General Information
MW Meds Ltd is a private company, limited by shares, registered in England and Wales, registration number 11562733, registration address 378 Idle Road, Five Lane Ends, Bradford, West Yorkshire, BD2 2AW.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Going concern basis
The director believes that the company is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Dividends
Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date.
2.

Average number of employees

Average number of employees during the year was 1 (2022 : 1).

3.

Directors' Loan Account

At 30 September 2023, the directors loan accounts of £488(2022: £1,069) are unsecured, repayable on demand and interest free. During the period the directors incurred the following transactions:
Director   Balance B/F
£
  Advances
£
  Credits
£
  Balance C/F
£
M Waqas 1,069  (68,247) 68,735  488 



For the year ended 30 September 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts.
The financial statements were approved by the director on 23 September 2024 and were signed by:


--------------------------------
M Waqas
Director
1